tiprankstipranks
Trending News
More News >
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market

BioNexus Gene Lab Corp (BGLC) Income Statement

Compare
112 Followers

BioNexus Gene Lab Corp Income Statement

Last quarter (Q3 2025), BioNexus Gene Lab Corp's total revenue was $2.54M, a decrease of -3.29% from the same quarter last year. In Q3, BioNexus Gene Lab Corp's net income was $-708.99K. See BioNexus Gene Lab Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.51M$ 9.77M$ 10.93M$ 13.36M$ 11.39M
Gross Profit
$ 1.29M$ 1.33M$ 1.26M$ 2.19M$ 1.72M
Operating Expenses
$ 2.86M$ 3.92M$ 1.55M$ 1.14M$ 446.00K
Depreciation and Amortization
$ 153.14K$ 108.42K$ 105.42K$ 108.22K$ 101.60K
EBITDA
$ -1.42M$ -2.49M$ -185.76K$ 1.16M$ 1.38M
Operating Income
$ -1.57M$ -2.59M$ -291.18K$ 1.06M$ 1.27M
Other Income/Expenses
$ -21.15K$ -13.93K$ -12.48K$ -12.97K$ -11.31K
Pretax Income
$ -1.59M$ -2.61M$ -303.66K$ 1.04M$ 1.26M
Net Income
$ -1.60M$ -2.63M$ -355.97K$ 751.57K$ 1.09M
Per Share Metrics
Basic EPS
$ -0.90$ -1.53$ -0.25$ 0.53$ 1.28
Diluted EPS
$ -0.90$ -1.53$ -0.25$ 0.53$ 1.28
Weighted Average Shares Outstanding
1.78M 1.72M 1.44M 1.43M 857.65K
Weighted Average Shares Outstanding (Diluted)
1.78M 1.72M 1.44M 1.43M 857.65K
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History